The Soluble Plasminogen Activator Receptor as a Biomarker on Monitoring the Therapy Progress of Pulmonary TB-AFB(+) Patients

Table 1

Clinical data of patients included in the study.

No	Patients’ characteristics	Frequency (n)	Percentage (%)
1	Number of patients	20	100%
	Male	10	50%
	Female	10	50%
2	Age (years); age median = 30 years
	19–30	12	60%
	31–40	4	20%
	41–50	4	20%
3	Width of lesion classification
	Minimal lesion	1	5%
	Moderate advance lesion	7	35%
	Far advance lesion	12	60%
4	Patients’ complaints
	Chronic cough $>$3 weeks	20	100%
	Decrease of appetite	15	75%
	Low grade fever	10	50%
	Shortness of breath	9	45%
	Hemoptoe	9	45%
	Chest pain	2	10%